Anagenex
Anagenex: A seed-stage biotech firm innovating drug discovery for challenging targets.
Founded
2020Anagenex: A seed-stage biotech firm innovating drug discovery for challenging targets.
Anagenex, founded as a seed-stage biotechnology company, is dedicated to revolutionizing drug discovery by focusing on challenging targets. Their core mission is to expedite the process of turning scientific ideas into effective medicines, leveraging AI-driven platforms to overcome traditional bottlenecks in drug development. Anagenex aims to address the inefficiencies in current drug discovery methods by utilizing AI-scale data, enabling faster and more accurate identification of potential treatments for various diseases.
Notable figures associated with Anagenex include experts in biotechnology and AI, though specific names are not highlighted. The company has garnered attention from investors interested in innovative biotech solutions. Key achievements include developing a novel platform that significantly reduces the time required to discover and refine new drugs. Anagenex's impact lies in its potential to transform the pharmaceutical industry by making drug discovery more efficient and accessible, ultimately benefiting patients who need timely medical interventions.
Companies similar to Anagenex include Anji Pharmaceuticals, Algen Biotechnologies, Animol Discovery and Model Medicines.
Anagenex was founded in 2020.
Anagenex's headquarters is located in San Francisco, CA, US.
Anagenex's most recent funding round was for $30M (USD) in June 2022.
As of Jun 8, 2022, Anagenex has disclosed funding of $37.2M (USD). Undisclosed round amounts are excluded.
Anagenex has 27 employees as of Feb 4, 2024.
Model Medicines
modelmedicines.com
